Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
25 drugs in development
By Therapeutic Area
top 6
R&D Momentum
88/100
Pipeline Velocity
62/100
Trial Completion Rate
69/100
Pipeline Concentration
12/100
Pipeline Freshness
61/100
Strategic Signals
Activity
Last 14 days
Moving Yourself in Space and Time Identifying Spatial and Temporal Components of Complex Rhythmic Movement Training for People With Parkinson's Disease and Cognitive Impairment
Georgia Memory Net Center for Medicare and Medicaid Services Registry for Anti-Amyloid Monoclonal Antibody Coverage With Evidence Development
Inspiring Seniors Towards Exercise Promotion - 2
A Pilot Study of MDMA-Assisted Massed Exposure Therapy for PTSD (MDMA PE)
Voice2Manage: Interactive Voice-Assisted Self-Management Intervention for Low-Income Older Adults
Prevent Allergic Reactions to Aphexda With Dexamethasone (PARADE)
Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
Combustion of Plastic Waste and Human Health Effects in Guatemala
"I Can Do This! Managing My Diabetes: A Pilot Project Using a Novel Word Game-based Workbook Intervention to Allow People Living With Diabetes to Increase Their Diabetes Self-efficacy"
PREVENT Study: Promoting Resilience Via Early Neurostimulation After Trauma
Ventricular Tachycardia Substrate Mechanisms Revealed by Local Repolarization and Conduction Parameters
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)